News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mitsubishi Pharma Corporation To License ZIONE Internal Hemorrhoid Drug To Yuhan Corporation



2/24/2006 11:35:52 AM

Osaka, Feb 24, 2006 (JCN) - Mitsubishi Pharma and Lequio Pharma jointly announced on February 23 that they have signed a licensing agreement with Korean pharmaceutical company Yuhan Corporation. Under the terms of the agreement, Yuhan receives the exclusive right to import and market ZIONE Injection in Korea. Yuhan aims to launch the agent as soon as possible.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES